DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC
Google image searchProduct monograph
Active ingredient
sodium iodide 131 i, 925 MBq/VIAL
DIN: 02329786
Dosage form(s): SOLUTION
Route(s) of administration: ORAL
Description: 74 TO 925 MBQ/ VIAL
Schedule: Schedule C
Company: JUBILANT DRAXIMAGE INC. DBA JUBILANT RADIOPHARMA
Date: 14-NOV-2018
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09F — THYROID (ATC, ATC/DDD)
- V09FX — Various thyroid diagnostic radiopharmaceuticals (ATC, ATC/DDD)
- V09FX03 — SODIUNM IODIDE 131 I (ATC/DDD)
Pharmaceutical standard: USP
